Roundtables continue to be packed with attendees and full of thought-provoking, collaborative discussions. #casss #HOS2024 #MassSpec2024 #MassSpec #MassSpectrometry #biopharmaceuticals
CASSS – Sharing Science Solutions’ Post
More Relevant Posts
-
What lies ahead for Nanexa? Join CEO David Westberg & CFO Björn Svanström as they take a wide range of questions on everything from projects to partnerships from a panel of expert analysts. Watch the Q&A (in Swedish, with some questions in English) HERE: https://lnkd.in/d-ehPMMW #diabetes #multiplemyeloma #drugformulation #drugdelivery #drugdevelopment #pharmacetuicals #biopharmaceuticals #longactinginjectables #monoclonalantibodies #longactingmonoclonalantibodies
-
-
In our latest collaborative application note with Analytik Jena, we present the Microsart®️ ATMP Mycoplasma Assay's integration with the qTOWER iris 96 and 384 systems. This documentation provides insights into the assay's adherence to European Pharmacopoeia standards for mycoplasma testing. Key findings include: 🔍 Quantitative PCR allows for precise genomic copy number determination. 📈 The assay demonstrates consistent PCR efficiency and homogeneity across replicates. 🧪 Comparative analysis between qTOWER iris 96 and 384 models indicates suitability for high-throughput applications. Learn more: https://ow.ly/xKPZ50So7bL #Mycoplasma #CellTherapeutics #qPCR #Biopharmaceutical #QualityAssurance #Sartorius #AnalytikJena #QualityControl
-
-
The Octet BLI platform allows direct detection of specific proteins or drug molecules, even in complex mixtures and unpurified samples such as cell culture supernatants and lysates. learn more at: https://lnkd.in/gNruiE9k
Explore the capabilities of the Octet®- Affinity, Binding Kinetics and Concentration®️ in assessing biosimilarity across upstream and downstream processes. Our latest application note demonstrates a high-throughput approach for rapid testing of development samples against key ligands, meeting stringent regulatory requirements. Access the full application note for insights into optimizing biosimilar development workflows: https://ow.ly/JPxw50SsJvo #Biosimilarity #OctetBLI #Biopharmaceuticals #qualitycontrol
-
-
7 days to go before #BPIWest begins in #sandiego. If you will be attending let's talk about your 2024 priorities and the new additions to Lonza's GS System and how it can help you from discovery all the way through CMC and into commercial production and supply. If you are working on #immunooncology therapeutics we can help there too. Looking forward to meeting new people and helping bring any therapy to life. #antibodytherapeutics #lonza #bispecifics #biopharmaceuticals #drugdevelopment
-
-
At the latest #ISOQOL conference, Dana DiBenedetti, PhD, Vice President of Patient-Centered Outcomes Assessment presented information on Innovations in in-trial interviews: novel approaches to capturing the patient experience in quality of life research. Read more about those approaches here: https://ow.ly/mkE350PVeOU #HCQoL #patientvoice #clinicianreported #patientcentered #biopharmaceuticals #drugdevelopment
-
Another analytical standalone service of Coriolis Pharma: particle identification 🆔 🔥 Despite the fact that the pharmaceutical industry is putting a lot of efforts into ensuring safe and efficient processes (#CMC), visible particles in parenteral formulations still remain one of the Top 3 reasons for costly product recalls and/or regulatory audit observations. 👩🔬 👨🔬 With the support of Coriolis' subject matter experts, we will support your particle investigation by careful interpretation of the results. Our fast turnaround time from sample receipt to results presentation will help you saving precious time. The reporting and documentation is designed to reliably assist you, allowing you to focus on resolving the issue fast. 👌 ⁉ Curious to learn more about this service? Do not hesitate to contact my colleague Daniel Weinbuch or me now! #particleID #drugproduct #visibleparticles
💡 Did you know that #Coriolis offers different service models for Particle Identification and is able to deliver results within days? 💡 Find out more about this offering and connect with Daniel Weinbuch, Evelyn Eggenstein or Michel Croes or simply visit our website 👉 https://lnkd.in/dqrRvKGj. #CoriolisPharma #Particles #ParticleIdentification #Biopharmaceuticals
-
Enhancing Development Success Through a Robust Developability Assessment Tool Read the article here - https://lnkd.in/gik7U2w3 #Biopharmaceuticals #DrugDevelopment #ClinicalSuccess #DevelopabilityAssessment #PharmaTech
-
-
CMC, Post Approval Changes (PAC), RCGM, MAA. CDSCO, Biologicals, Vaccines & rDNA products, Clinical Trials, Dossier CTD, ACTD, NSWS, Regulatory Science, Drug Regulatory Affairs, Biosimilar.
Hi Connections, With reference to DCGI new portal ie NSWS, DCGI issued notification related to exisiting SUGAM portal will be disable for Below application activities -CT-10, -CT-12, -CT-13, -CT-16 and -Form 12. This will be applicable with immediate effect from 24.01.2024 and SUGAM portal will be disable from 10.02.2024 for said applications. #cdsco #clinicaltrials #biologicals #pharmaceuticalindustry #biopharmaceuticals #regulatoryaffairs #regulatorysubmissions #regulatorycompliance
-
-
FabRICATOR used in an Capillary Gel Electrophoresis application - I will of course listen to this webinar. Why don't you sign up as well :-) #CapillaryElectrophoresis #FabRICATOR #SmartEnzymes
New year, new GenovisWebinar! 🤩🎉 We are excited to start the new year by announcing the speaker for our first GenovisWebinar in 2024! We are delighted to welcome Andrew McClain from Bristol Myers Squibb to talk about his experiences using FabRICATOR® and how he and his team have used it to solve a unique separation challenge encountered when using Non-Reducing Capillary Electrophoresis! 👀 Learn more about this event and register here ☞ https://lnkd.in/d4rqaNt2 #Biopharma #Biopharmaceuticals #mAbs #CapillaryElectrophoresis #AnalyticalWorkflows #QualityControl #AnalyticalSeparation #FabRICATOR #IdeS #Genovis #SmartEnzymes
-
